GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human gac in complex with inhibitor UPGL00018

Analyse Crystal structure of human gac in complex with inhibitor UPGL00018 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6UK6
Type
protein
Length
1,601 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O94925
Ligands
Q9S

Structure

x-ray diffraction · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein404—O94925
B—protein398—O94925
C—protein402—O94925
D—protein397—O94925

Ligands and binding sites

  • Q9S · 5-{4-[(5-amino-1,3,4-thiadiazol-2-yl)oxy]piperidin-1-yl}-1,3,4-thiadiazol-2-amine · ligand · 2 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6UK6 · Crystal structure of human GAC in complex with inhibitor UPGL00018 · the same entry in another collection · chain D against D, TM-score 1.00
  • O94925 · AlphaFold monomer V2.0 prediction for glutaminase kidney isoform, mitochondrial (O94925) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.